Trial Profile
A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dexamethasone
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms ADAM
- 28 Jul 2021 Status changed from recruiting to discontinued.
- 22 Feb 2017 Status changed from not yet recruiting to recruiting.
- 28 Apr 2016 New trial record